110 related articles for article (PubMed ID: 22544282)
1. Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma.
Macaluso M; Caracciolo V; Rizzo V; Sun A; Montanari M; Russo G; Bellipanni G; Khalili K; Giordano A
Cell Cycle; 2012 May; 11(9):1841-50. PubMed ID: 22544282
[TBL] [Abstract][Full Text] [Related]
2. CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.
Fiorentino FP; Macaluso M; Miranda F; Montanari M; Russo A; Bagella L; Giordano A
Mol Cancer Res; 2011 Feb; 9(2):225-33. PubMed ID: 21325284
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell death and selection: unexpected putative roles for pRb2/p130, BORIS and CTCF in endoplasmic stress response maintained by the T-antigen.
Bronner C; Hamiche A
Cell Cycle; 2012 Jun; 11(11):2052. PubMed ID: 22627611
[No Abstract] [Full Text] [Related]
4. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo.
Howard CM; Claudio PP; Gallia GL; Gordon J; Giordano GG; Hauck WW; Khalili K; Giordano A
J Natl Cancer Inst; 1998 Oct; 90(19):1451-60. PubMed ID: 9776410
[TBL] [Abstract][Full Text] [Related]
5. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE
Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099
[TBL] [Abstract][Full Text] [Related]
6. CTCF inhibits endoplasmic reticulum stress and apoptosis in cardiomyocytes by upregulating RYR2 via inhibiting S100A1.
Zeng Z; Huang N; Zhang Y; Wang Y; Su Y; Zhang H; An Y
Life Sci; 2020 Feb; 242():117158. PubMed ID: 31837328
[TBL] [Abstract][Full Text] [Related]
7. A cell cycle role for the epigenetic factor CTCF-L/BORIS.
Rosa-Garrido M; Ceballos L; Alonso-Lecue P; Abraira C; Delgado MD; Gandarillas A
PLoS One; 2012; 7(6):e39371. PubMed ID: 22724006
[TBL] [Abstract][Full Text] [Related]
8. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in the mitochondrial apoptotic pathway reveals the toxic potential of autophagy under ER stress conditions.
Deegan S; Saveljeva S; Logue SE; Pakos-Zebrucka K; Gupta S; Vandenabeele P; Bertrand MJ; Samali A
Autophagy; 2014; 10(11):1921-36. PubMed ID: 25470234
[TBL] [Abstract][Full Text] [Related]
10. The evolution of epigenetic regulators CTCF and BORIS/CTCFL in amniotes.
Hore TA; Deakin JE; Marshall Graves JA
PLoS Genet; 2008 Aug; 4(8):e1000169. PubMed ID: 18769711
[TBL] [Abstract][Full Text] [Related]
11. CTCF and BORIS in genome regulation and cancer.
Marshall AD; Bailey CG; Rasko JE
Curr Opin Genet Dev; 2014 Feb; 24():8-15. PubMed ID: 24657531
[TBL] [Abstract][Full Text] [Related]
12. Widespread expression of BORIS/CTCFL in normal and cancer cells.
Jones TA; Ogunkolade BW; Szary J; Aarum J; Mumin MA; Patel S; Pieri CA; Sheer D
PLoS One; 2011; 6(7):e22399. PubMed ID: 21811597
[TBL] [Abstract][Full Text] [Related]
13. The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence.
Helmbold H; Galderisi U; Bohn W
J Cell Physiol; 2012 Feb; 227(2):508-13. PubMed ID: 21465484
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between T-Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma.
Caracciolo V; Macaluso M; D'Agostino L; Montanari M; Scheff J; Reiss K; Khalili K; Giordano A
J Cell Biochem; 2010 May; 110(1):182-90. PubMed ID: 20336668
[TBL] [Abstract][Full Text] [Related]
16. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.
Debruyne DN; Dries R; Sengupta S; Seruggia D; Gao Y; Sharma B; Huang H; Moreau L; McLane M; Day DS; Marco E; Chen T; Gray NS; Wong KK; Orkin SH; Yuan GC; Young RA; George RE
Nature; 2019 Aug; 572(7771):676-680. PubMed ID: 31391581
[TBL] [Abstract][Full Text] [Related]
17. Critical role for the transcription regulator CCCTC-binding factor in the control of Th2 cytokine expression.
Ribeiro de Almeida C; Heath H; Krpic S; Dingjan GM; van Hamburg JP; Bergen I; van de Nobelen S; Sleutels F; Grosveld F; Galjart N; Hendriks RW
J Immunol; 2009 Jan; 182(2):999-1010. PubMed ID: 19124743
[TBL] [Abstract][Full Text] [Related]
18. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer.
Klenova EM; Morse HC; Ohlsson R; Lobanenkov VV
Semin Cancer Biol; 2002 Oct; 12(5):399-414. PubMed ID: 12191639
[TBL] [Abstract][Full Text] [Related]
19. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
20. MAGEA1 inhibits the expression of BORIS via increased promoter methylation.
Zhao J; Wang Y; Liang Q; Xu Y; Sang J
J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
